All news
Neutral impactCorporate Action

SPML Infra Limited — Credit Rating- New

NSE 3 Jul·3 Jul 2026, 2:41 am

SPML Infra Limited has informed the Exchange about Credit Rating- New

Stocks in this story

Speciality Medicines193.00 0.00%

Key takeaways

  • Concerns Speciality Medicines (SPML).
  • Category: Corporate Action.

Why it matters

A routine update for Speciality Medicines. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.

SPML Infra Limited — Credit Rating- New | Speciality Medicines (SPML)